106 related articles for article (PubMed ID: 11440775)
1. Lower prolactin bioactivity in unmedicated schizophrenic patients.
Warner MD; Walker AM; D'Souza DC; Lee D; Nasseri D; Peabody CA
Psychiatry Res; 2001 Jul; 102(3):249-54. PubMed ID: 11440775
[TBL] [Abstract][Full Text] [Related]
2. Prolactin bioassay in schizophrenia before and after neuroleptics.
Peabody CA; Warner MD; Griffin M; Boutros NN; Worsley IG; Friesen HG
Psychiatry Res; 1992 Mar; 41(3):249-55. PubMed ID: 1594711
[TBL] [Abstract][Full Text] [Related]
3. Characterization of big, big prolactin in patients with hyperprolactinaemia.
Leite V; Cosby H; Sobrinho LG; Fresnoza MA; Santos MA; Friesen HG
Clin Endocrinol (Oxf); 1992 Oct; 37(4):365-72. PubMed ID: 1483294
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Nb2 bioassay and radioimmunoassay values for human serum prolactin.
Rowe RC; Cowden EA; Faiman C; Friesen HG
J Clin Endocrinol Metab; 1983 Nov; 57(5):942-6. PubMed ID: 6413527
[TBL] [Abstract][Full Text] [Related]
5. Serum prolactin and growth hormone determined by radioimmunoassay and a two-site immunoradiometric assay: comparison with the Nb2 cell bioassay.
Rose DP; Berke B; Cohen LA
Horm Metab Res; 1988 Jan; 20(1):49-53. PubMed ID: 3371857
[TBL] [Abstract][Full Text] [Related]
6. Prolactin bioassay and hyperprolactinemia.
Peabody CA; Schultz PN; Warner MD; Worsley IG; Friesen HG; Samaan NA
J Endocrinol Invest; 1992; 15(7):497-9. PubMed ID: 1360020
[TBL] [Abstract][Full Text] [Related]
7. Euprolactinemic Galactorrhea. Response of bioassayable prolactin to thyrotropin-releasing hormone.
Ataya KM; Subramanian MG; Lawson DM; Gala RR
J Reprod Med; 1996 Mar; 41(3):156-60. PubMed ID: 8778412
[TBL] [Abstract][Full Text] [Related]
8. Correlation and comparison of Nb2 lymphoma cell bioassay with radioimmunoassay for human prolactin.
Subramanian MG; Spirtos NJ; Moghissi KS; Magyar DM; Hayes MF; Gala RR
Fertil Steril; 1984 Dec; 42(6):870-4. PubMed ID: 6500079
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Nb2 lymphoma cell bioassay with immunoassay for human prolactin: the role of estrogen.
Nader S; Warner MD; Friesen HG; Peabody CA
J Endocrinol Invest; 1992 Apr; 15(4):303-5. PubMed ID: 1512421
[TBL] [Abstract][Full Text] [Related]
10. Plasma fluphenazine and prolactin levels in schizophrenic patients during treatment with low and high doses of fluphenazine enanthate.
Wiles D; Franklin M; Dencker SJ; Johansson R; Lundin L; Malm U
Psychopharmacology (Berl); 1980; 71(2):131-6. PubMed ID: 6777812
[TBL] [Abstract][Full Text] [Related]
11. Electrophoretically separable forms of rat prolactin with different bioassay and radioimmunoassay activities.
Asawaroengchai H; Russell SM; Nicoll CS
Endocrinology; 1978 Feb; 102(2):407-14. PubMed ID: 743965
[TBL] [Abstract][Full Text] [Related]
12. Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women.
Muck-Seler D; Pivac N; Mustapic M; Crncevic Z; Jakovljevic M; Sagud M
Psychiatry Res; 2004 Jul; 127(3):217-26. PubMed ID: 15296821
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of biological activity of prolactin molecular weight variants in human sera.
Whitaker MD; Klee GG; Kao PC; Randall RV; Heser DW
J Clin Endocrinol Metab; 1984 May; 58(5):826-30. PubMed ID: 6707188
[TBL] [Abstract][Full Text] [Related]
14. Stability of serum neuroleptic and prolactin concentrations during short- and long-term treatment of schizophrenic patients.
Rao ML; Brown WA
Psychopharmacology (Berl); 1987; 93(2):237-42. PubMed ID: 2892222
[TBL] [Abstract][Full Text] [Related]
15. A study of serum prolactin levels in schizophrenia: comparison of males and females.
Kuruvilla A; Peedicayil J; Srikrishna G; Kuruvilla K; Kanagasabapathy AS
Clin Exp Pharmacol Physiol; 1992 Sep; 19(9):603-6. PubMed ID: 1356671
[TBL] [Abstract][Full Text] [Related]
16. Serum prolactin response to chlorpromazine and psychopathology in schizophrenics: implications for the dopamine hypothesis.
Meltzer HY; Busch D
Psychiatry Res; 1983 Aug; 9(4):285-99. PubMed ID: 6580661
[TBL] [Abstract][Full Text] [Related]
17. Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
Chouinard G; Annable L; Jones BD; Collu R
Acta Psychiatr Scand; 1981 Nov; 64(5):353-62. PubMed ID: 6126066
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of prolactin bioassay in euprolactinemic reproductive disorders.
Ataya KM; Subramanian MG; Moghissi KS; Magyar DM; Hayes MF; Lawson DM; Gala RR
Fertil Steril; 1988 Jan; 49(1):71-5. PubMed ID: 3335274
[TBL] [Abstract][Full Text] [Related]
19. Relationship between bioassay and radioimmunoassay measurement of prolactin in the IPL rat, a hypoprolactinemic rat strain.
Cohen H; Sabbagh I; Guillaumot P; Bertrand J; Robertson M; Friesen HG
Biol Reprod; 1988 Feb; 38(1):84-90. PubMed ID: 3365473
[TBL] [Abstract][Full Text] [Related]
20. Elevated growth hormone levels in sera from breast cancer patients.
Emerman JT; Leahy M; Gout PW; Bruchovsky N
Horm Metab Res; 1985 Aug; 17(8):421-4. PubMed ID: 4054832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
